Cogstate Ltd (AU:CGS) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cogstate Ltd, a company specializing in neuroscience technology for brain health assessments, has announced its FY2024 Annual General Meeting (AGM) to be held as a hybrid event. The provided AGM documents include a Notice of Meeting and a Sample Proxy for shareholders. Cogstate, known for advancing medicine development and clinical insights, partners with pharma giant Eisai to distribute assessments in the USA & Asia.
For further insights into AU:CGS stock, check out TipRanks’ Stock Analysis page.